Clinical Significance of the t(14;18) And BCL2 Overexpression in Follicular Large Cell Lymphoma

References

• The Non-Hodgkin's Lymphoma Pathologic Classification Project. National Cancer Institute sponsored study of classification of non-Hodgkin's lymphomas. Summary and description of a working formulation for clinical usage. aCncer 1981; 49: 2112–35
   Web of Science ®Google Scholar
• Kantarjian H. M., McLaughlin P., Fuller L. M., Dixon D. O., Osborne B. M., Cabanillas F. F. Follicular large cell lymphoma: Analysis and prognostic factors in 62 patients. J. Clin. nOcol. 1984; 2: 811–19
   PubMed Web of Science ®Google Scholar
• Bartlett N. L., Rizeq M., Dorfman R. F., Halpern J., Horning S. J. Follicular large-cell lymphoma: Intermediate or low grade?. J. Clin. Oncol 1994; 12: 1349–57
   PubMed Web of Science ®Google Scholar
• Martin A. R., Weisenburger D. D., Chan W. C., Ruby E. I., Anderson J. R., Vose J. M., Bierman P. J., Bast M. A., Daley D. T., Armitage J. O. Prognostic value of cellular proliferation and histologic grade in follicular lymphoma. Blood 1995; 85: 3671–78
   PubMed Web of Science ®Google Scholar
• Wendum D., Sebban C., Gaulard P., Coiffier B., Tilly H., Cazals D., Boehn A., Casasnovas R. O., Bouabdallah R., Jaubert J., Ferrant A., Diebold J., de Mascarel A., Gis-selbrecht C. Follicular large-cell lymphoma treated with intensive chemotherapy: Analysis of 89 cases included in the LNH87 trial and comparison with the outcome of diffuse large B-cell lymphoma. J. Clin. Oncol. 1997; 15: 1654–63, for the Group d'Etude des Lymphomes de l'Adulte
   PubMed Web of Science ®Google Scholar
• Armitage J. O., Weisenburger D. D. New approach to classifying non-Hodgkin's lymphomas: Clinical features of the major histologic types. J. Clin. Oncol. 1998; 16: 2780–95, for the Non-Hodgkin's Lymphoma Classification Project
   PubMed Web of Science ®Google Scholar
• Miller T. P., LeBlanc M., Grogan T. M., Fischer R. I. Follicular lymphomas: Do histologic subtypes predict outcome?. Hematol. Oncol. Clin. North Am. 1997; 11: 893–900
   PubMed Web of Science ®Google Scholar
• Yunis J. J., Frizzera G., Oken M. M., McKenna J., Theologides A., Arneson M. Multiple recurrent genomic defects in follicular lymphoma. N. Engl. J. Med. 1987; 316: 79–84
   PubMed Web of Science ®Google Scholar
• Weiss L. M., Wamke R. A., Sklar J., Cleary M. L. Molecular analysis of the t(14; 18) chromosomal transloca-tion in malignant lymphomas. N. Engl. J. Med. 1987; 317: 1185–89
   PubMed Web of Science ®Google Scholar
• Offit K., Jhanwar S. C., Ladanyi M., Filippa D. A., Chaganti R. S. K. Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: Correlations between recurrent aberrations, histology, and exposure to cytotoxic treatment. Genes Chrom. Cancer 1991; 3: 189–201
   PubMed Web of Science ®Google Scholar
• Zelenetz A. D., Chu G., Galili N., Bangs C. D., Horning S. J., Donlon T. A., Cleary M. L., Levy R. Enhanced detection of the t(14;18) translocation in malignant lymphoma using pulsed-field gel electrophoresis. Blood 1991; 78: 1552–60
   PubMed Web of Science ®Google Scholar
• Tilly H., Rossi A., Stomatoullas A., Lenormand B., Big-orgne C., Kunlin A., Monconduit M., Bastard C. Prognostic value of chromosomal abnormalities in follicular lymphoma. Blood 1994; 84: 1043–49
   PubMed Web of Science ®Google Scholar
• Turner G. E., Ross F. M., Krajewski A. S. Detection of t(14; 18) in British follicular lymphoma using cytoge-netics. Southern blotting and the polymerase chain reaction. Br. J. Haematol. 1995; 89: 223–25
   PubMed Web of Science ®Google Scholar
• Horsman D. E., Gascoyne R. D., Coupland R. W., Coldman A. J., Adomat S. E. Comparison of cytogenetic analysis, Southern analysis, and polymerase chain reaction for the detection of t(14;18) in follicular lymphoma. Am. J. Clin. Pathol. 1995; 103: 472–78
   PubMed Web of Science ®Google Scholar
• Poetsch M., Weber-Matthiesen K., Plendl H. J., Grote W., Schlegelberger B. Detection of the t(14;18) chromosomal translocation by interphase cytogenetics with yeast-artificial chromosome probes in follicular lymphoma and nonneoplastic lymphoproliferation. J. Clin. Oncol. 1996; 14: 963–69
   PubMed Web of Science ®Google Scholar
• Meijerink J. P. P. t(14;18), a journey to eternity. Leuk. 1997; 11: 2175–87
   PubMed Web of Science ®Google Scholar
• Shibata D., Hu E., Weiss L.M., Brynes R. K., Nathwani B. N. Detection of specific t(14; 18) chromosomal translocations in fixed tissues. Hum. Pathol. 1990; 21: 199–203
   PubMed Web of Science ®Google Scholar
• Pezzella F., Jones M., Ralfkiaer E., Ersboll J., Gatter K. C., Mason D. Y. Evaluation of bcl-2 protein expression and 14:18 translocations as prognostic markers in follicular lymphoma. Br. J. Cancer 1992; 65: 87–89
   PubMed Web of Science ®Google Scholar
• Gaulard P., d'Agay M. F., Peuchmaur M., Brousse N., Gis-selbrecht C., Solol-Celigny P., Diebold J., Mason D.Y. Expression of the bcl-2 gene product in follicular lymphoma. Am. J. Pathol. 1992; 140: 1089–95
   PubMed Web of Science ®Google Scholar
• Liu J., Johnson R. M., Traweek S. T. Rearrangement of the bcl-2 gene in follicular lymphoma. Diagn. Mol. Pathol. 1993; 2: 241–47
   PubMed Web of Science ®Google Scholar
• Utz G. L., Swerdlow S. H. Distinction of follicular hyperplasia from follicular lymphoma in B5-fixed tissues: Comparison of MT2 and bcl-2 antibodies. Hum. Pathol. 1993; 24: 1155–58
   PubMed Web of Science ®Google Scholar
• Gelb A. B., Rouse R. V., Dorfman R. F., Warnke R. A. Detection of immunophenotypic abnormalities in paraffin-embedded B-lineage non-Hodgkin's lymphomas. Am. J. Clin. Pathol. 1994; 102: 825–34
   PubMed Web of Science ®Google Scholar
• Lai R., Arber D. A., Chang K. L., Wilson C. S., Weiss L. M. Frequency of bcl-2 expression in non-Hodgkin's lymphoma: A study of 778 cases with comparison of marginal zone lymphoma and monocytoid B-cell hyperplasia. Mod. Pathol. 1998; 11: 864–69
   PubMed Web of Science ®Google Scholar
• Hermine O., Haioun C., Lepage E., d'Agay M. F., Brieve J., Lavignac C., Fillet G., Salles G., Marolleau J. P., Die-bold J., Reyes F., Gaulard P. Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin's lymphoma. Blood 1996; 87: 265–72, for the Groupe d'Etude des Lymphomes de l'Adulte (GELA)
   PubMed Web of Science ®Google Scholar
• Hill M. E., MacLennan K. A., Cunningham D. C., Vaughan Hudson B., Burke M., Clarke P., Di Stefano F., Anderson L., Vaughn Hudson G., Mason D., Selby P., Linch DC. Prognostic significance of BCL-2 expression and bcl-2 major breakpoint region rearrangement in diffuse large cell non-Hodgkin's lymphoma: A British National Lymphoma Investigation study. Blood 1996; 88: 1046–51
   PubMed Web of Science ®Google Scholar
• Gascoyne R. D., Adomat S. A., Krajewski S., Krajewski M., Horsman D. E., Tolcher A. W., O'Reilly S. E., Hoskins P., Coldman A. J., Reed J. C., Connors J. M. Prognostic significance of BCL-2 protein expression and BCL-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma. Blood 1997; 90: 244–51
   PubMed Web of Science ®Google Scholar
• Kramer M. H. H., Hermans J., Wijburg E., Phillipo K., Geelen E., vanKrieken J. H. J. M., de Jong D., Maartense E., Schuuring E., Kluin P. M. Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma. Blood 1998; 92: 3152–62
   PubMed Web of Science ®Google Scholar
• Yunis J. J., Mayer M. G., Arnesen M. A., Aeppli D. P., Oken M. M., Frizzera G. bcl-2 and other genomic alterations in the prognosis of large-cell lymphoma. N. Engl. J. Med. 1989; 320: 1047–54
   PubMed Web of Science ®Google Scholar
• Mann R. B., Berard C. W. Criteria for the cyto-logic subclassification of follicular lymphomas: A proposed alternative method. Hematol. Oncol. 1983; 1: 187–92
   PubMedGoogle Scholar
• Vose J. M., Anderson J. R., Bierman P. J., Bast M., Weisenburger D. D., Chan W. C., Bishop M. R., Armitage J. O. Comparison of front-line chemotherapy for aggressive non-Hodgkin's lymphoma using the CAP-BOP regimens. Sem. Hematol. 1994; 31: 4–8
   PubMed Web of Science ®Google Scholar
• Hoskins P. J., Le N., Gascoyne R. D., Klasa R., Shenkier T., O'Reilly S. E., Connors J. M. Advanced diffuse large-cell lymphoma treated with 12-week combination chemotherapy: Natural history of relapse after initial complete response and prognostic variables defining outcome after relapse. Ann. Oncol. 1997; 8: 1125–32
   PubMed Web of Science ®Google Scholar
• Nashelsky M. B., Hess M. M., Weisenburger D. D., Pierson J. C., Bast M. A., Armitage J. O., Sanger W. G. Cytogenetic abnormalities in B-immunoblastic lymphoma. Leuk. Lymphoma 1994; 14: 415–20
   PubMed Web of Science ®Google Scholar
• Cancer Cytogenetics: Supplement to An International System for Human Cytogenetic Nomenclature. S Karger Publishers, Inc, Basel 1991
   Google Scholar
• Gribben J. G., Freedman A. S., Woo S. D., Blake K., Shu R. S., Freeman G., Longtine J. A., Pinkus G. S., Nadler L. M. All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of hcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment. Blood 1991; 78: 3275–80
   PubMed Web of Science ®Google Scholar
• Sharp J. G., Bishop M., Chan W. C., Joshi S. S., Kessinger A., Mann S. L., Murphy B. O., Pirruccello S., Reed B., Sanger W., Traystman M., Vose J., Weekes C., Wu G. Application of malignant cell detection techniques to improve the outcome of high-dose therapy and transplantation for lymphoma, leukemia and breast cancer. Hematopoietic Stem Cell: The Method Manual, E. Wunder. Karger, Basel 1997, (in press)
   Google Scholar
• Hsu S. M., Raine L., Fanger H. Use of avi-din-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. Histochem. Cytochem. 1981; 29: 577–80
   PubMed Web of Science ®Google Scholar
• The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. N. Engl. J. Med. 1993; 329: 987–94
   PubMed Web of Science ®Google Scholar
• Kaplan G. L., Meier P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 1958; 53: 457–81
   Web of Science ®Google Scholar
• Monni O., Joensuu H., Fransilla K., Klefstrom J., Alitalo K., Knuutila S. BCL2 overexpression associated with chromosomal amplification in diffuse large B-cell lymphoma. Blood 1997; 90: 1168–74
   PubMed Web of Science ®Google Scholar
• Levine E. G., Arthur D. C., Frizzera G., Peterson B. A., Hurd D. D., Bloomfield C.D. Cytogenetic abnormalities predict clinical outcome in non-Hodgkin's lymphoma. Ann. Int. Med. 1988; 108: 14–20
   PubMed Web of Science ®Google Scholar
• Johnson A., Brun A., Dictor M., Rambech E., Akerman M., Anderson H. Incidence and prognostic significance of the t(14; 18) in follicle center cell lymphoma of low and high grade. Ann. Oncol. 1995; 6: 789–94
   PubMed Web of Science ®Google Scholar
• Simonian PL., Didier A.M., Grillot A. M., Nunez G. Bcl-2 and Bcl-XL can differentially block chemotherapy-induced cell death. Blood. 1997; 90: 1208–16
   PubMed Web of Science ®Google Scholar
• Zhou P., Qian L., Kozopas K.M., Craig R.N. Mcl-l, a Bcl-2 family member, delays the death of hemato-poietic cells under a variety of apoptosis-inducing conditions. Blood 1997; 89: 630–43
   PubMed Web of Science ®Google Scholar
• Sander C. A., Yono T., Clark H. M., Harris C., Longo D. L., Jaffe E. S., Raffeld M. p53 mutation is associated with progression in follicular lymphoma. Blood 1993; 82: 1994–2004
   PubMed Web of Science ®Google Scholar
• Lo Coco F., Gaidano G., Louie D. C., Offit K., Chaganti R. S. K., Dalla-Favera R. p53 mutations are associated with histologic transformation of follicular lymphoma. Blood 1993; 82: 2289–95
   PubMed Web of Science ®Google Scholar
• Lister T. A. Follicular lymphoma: Grounds for optimism. Ann. Oncol. 1997; 8(Suppl. 1)S89–92
   PubMedGoogle Scholar
• Tormo M., Tari A. M., McDonnell T. J., Cabanillas F., Gar-cia-Conde T., Lopez-Berestein G. Apoptotic induction in transformed follicular lymphoma cells by bcl-2 downregulation. Leuk. Lymphoma 1998; 30: 367–79
   PubMed Web of Science ®Google Scholar